Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
Clinical trial NCT07566364 · RECRUITING
Trial details
- NCT number
- NCT07566364
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-09
- Primary completion
- 2028-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.